Minocycline - Hovione

Drug Profile

Minocycline - Hovione

Alternative Names: HY-02

Latest Information Update: 20 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hovione
  • Class Amides; Antibacterials; Dimethylamines; Eye disorder therapies; Neuroprotectants; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Eye disorders

Most Recent Events

  • 20 Jul 2017 Chemical structure information added
  • 25 May 2017 Hovione has patent protection for HY02 and minocycline API in USA and European Union
  • 25 May 2017 Hovione has pending patents for HY02 and minocycline API worldwide
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top